Craft
  • Home
  •  / BenevolentAI
BenevolentAI

BenevolentAI

Trademarks Pending

2

May, 2020

Revenue

£6.8 M

FY, 2018

BenevolentAI Summary

Company summary

Overview
BenevolentAI is a clinical-stage AI-enabled drug discovery company. It offers an AI platform, scientific expertise, and wet-lab facilities. The Benevolent Platform powers a growing in-house pipeline of 20+ disease programs and maintains collaborations with other drug discovery companies and research and charitable institutions.
Type
Public
Founded
2013
HQ
London, GB | view all locations
Website
https://www.benevolent.com/
Cybersecurity rating
Sectors

Key people

  • John Orloff

    John Orloff, Non-Executive Director

    • Ivan Griffin

      Ivan Griffin, Chief Operating Officer and Co-Founder

      • Nigel Shadbolt

        Nigel Shadbolt, Non-Executive Director

        • Anne Phelan

          Anne Phelan, Chief Strategy Officer

        Operating MetricsView all

        Trademarks Pending

        2

        May, 2020

        LocationsView all

        3 locations detected

        • London, England HQ

          United Kingdom

          4-8 Maple St, Bloomsbury

        • New York, NY

          United States

          1 Dock 72 Way, 7th Floor

        • Babraham, England

          United Kingdom

          Babraham Hall House

        Footer menu